Arabic Arabic English English French French German German
dark

TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System

TransMedics Group, Inc. announced that after the review of TransMedics’ clinical evidence from the OCS Heart EXPAND trial, the associated Continued Access Protocol results, as well as the OCS Heart PROCEED II trial, the Circulatory Systems Device Advisory Panel convened by the U.S. Food and Drug Administration has issued a favorable vote in support of approval of the OCS Heart System to the FDA’s Office of Health Technology 2. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Canadian provider WELL Health Technologies snaps up EHR-focused Intrahealth Systems

Next Post

InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe

Related Posts
Total
0
Share